Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 17, 2022 - Issue
Submit an article Journal homepage
170
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET

Peter Alter1 Department of Medicine, Pulmonary and Critical Care Medicine, Philipps University of Marburg (UMR), Germany, Member of the German Center for Lung Research (DZL), Marburg, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2115-1743View further author information
ORCID Icon,
Kathrin Kahnert2 Department of Internal Medicine V, University Hospital, LMU Munich, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, GermanyView further author information
,
Franziska C Trudzinski3 Department of Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, GermanyORCID Iconhttps://orcid.org/0000-0002-0980-7586View further author information
ORCID Icon,
Robert Bals4 Department of Internal Medicine V - Pulmonology, Allergology, Intensive Care Medicine, Saarland University Hospital, Homburg, GermanyView further author information
,
Henrik Watz5 Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, GermanyView further author information
,
Tim Speicher1 Department of Medicine, Pulmonary and Critical Care Medicine, Philipps University of Marburg (UMR), Germany, Member of the German Center for Lung Research (DZL), Marburg, GermanyView further author information
,
Sandra Söhler1 Department of Medicine, Pulmonary and Critical Care Medicine, Philipps University of Marburg (UMR), Germany, Member of the German Center for Lung Research (DZL), Marburg, GermanyORCID Iconhttps://orcid.org/0000-0001-5851-1872View further author information
ORCID Icon,
Stefan Andreas6 LungClinic Immenhausen and Department of Cardiology and Pneumology, University Medical Center Göttingen, Germany, Member of the German Center for Lung Research (DZL), Göttingen, GermanyORCID Iconhttps://orcid.org/0000-0003-3918-6909View further author information
ORCID Icon,
Tobias Welte7 Clinic for Pneumology, Hannover Medical School, Member of the German Center for Lung Research (DZL), Hannover, GermanyORCID Iconhttps://orcid.org/0000-0002-9947-7356View further author information
ORCID Icon,
Klaus F Rabe8 LungenClinic Grosshansdorf and Department of Medicine, Christian-Albrechts University, Kiel, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, GermanyORCID Iconhttps://orcid.org/0000-0002-7020-1401View further author information
ORCID Icon,
Emiel FM Wouters9 Department of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, Netherlands and Ludwig Boltzmann Institute for Lung Health, Vienna, AustriaView further author information
,
Antonia Sassmann-Schweda10 Center for Clinical Studies, Research Center Borstel, Borstel, GermanyView further author information
,
Hubert Wirtz11 Department of Internal Medicine I, Pneumology, University of Leipzig, Leipzig, GermanyView further author information
,
Joachim H Ficker12 Department of Respiratory Medicine, Allergology and Sleep Medicine, Klinikum Nuremberg, Nürnberg, Germany;13 Paracelsus Medical University Nuremberg, Nürnberg, GermanyORCID Iconhttps://orcid.org/0000-0002-7175-5852View further author information
ORCID Icon,
Claus F Vogelmeier1 Department of Medicine, Pulmonary and Critical Care Medicine, Philipps University of Marburg (UMR), Germany, Member of the German Center for Lung Research (DZL), Marburg, GermanyView further author information
&
Rudolf A Jörres14 Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, GermanyORCID Iconhttps://orcid.org/0000-0002-9782-1117View further author information
ORCID Icon show all
Pages 1703-1713 | Received 02 Mar 2022, Accepted 21 Jul 2022, Published online: 29 Jul 2022

References

  • Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–735. doi:10.1164/rccm.201209-1665OC
  • Alter P, Mayerhofer BA, Kahnert K, et al. Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort. Int J Chron Obstruct Pulmon Dis. 2019;14:2163–2172. doi:10.2147/COPD.S209343
  • Karch A, Vogelmeier C, Welte T, et al. The German COPD cohort COSYCONET: aims, methods and descriptive analysis of the study population at baseline. Respir Med. 2016;114:27–37. doi:10.1016/j.rmed.2016.03.008
  • Alter P, Lucke T, Watz H, et al. Predictors of mortality and exacerbations in patients with stable COPD. Submitted. 2021;4:54.
  • Alter P, Baker JR, Dauletbaev N, et al. Update in chronic obstructive pulmonary disease 2019. Am J Respir Crit Care Med. 2020;202(3):348–355. doi:10.1164/rccm.202002-0370UP
  • Kahnert K, Alter P, Young D, et al. The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir Med. 2018;134:79–85. doi:10.1016/j.rmed.2017.12.003
  • Cazzola M, Bettoncelli G, Sessa E, Cricelli C, Biscione G. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration. 2010;80(2):112–119. doi:10.1159/000281880
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;49(3):1700214. doi:10.1183/13993003.00214-2017
  • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2022. Available from: https://goldcopd.org/2022-gold-reports-2/
  • Trudzinski FC, Kahnert K, Vogelmeier CF, et al. Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: results from the COSYCONET cohort. Respir Med. 2019;154:18–26. doi:10.1016/j.rmed.2019.06.007
  • Tietjens JR, Claman D, Kezirian EJ, et al. Obstructive sleep apnea in cardiovascular disease: a review of the literature and proposed multidisciplinary clinical management strategy. J Am Heart Assoc. 2019;8(1):e010440. doi:10.1161/JAHA.118.010440
  • Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312
  • Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122. doi:10.1186/1465-9921-11-122
  • Mullerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comorbidity in COPD: systematic literature review. Chest. 2013;144(4):1163–1178. doi:10.1378/chest.12-2847
  • Farzaneh-Far R, Cawthon RM, Na B, Browner WS, Schiller NB, Whooley MA. Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol. 2008;28(7):1379–1384. doi:10.1161/ATVBAHA.108.167049
  • Cherif H, Tarry JL, Ozanne SE, Hales CN. Ageing and telomeres: a study into organ- and gender-specific telomere shortening. Nucleic Acids Res. 2003;31(5):1576–1583. doi:10.1093/nar/gkg208

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.